Probabilistic Framework for the Estimation of the Adult and Child Toxicokinetic Intraspecies Uncertainty Factors

Risk Analysis

Volumn 23, Issue 6, 2003, Pages 1239-1255

  Pelekis, Michael ^a   Nicolich, Mark J ^a   Gauthier, Joseph S ^b  

^a Pelekis Group   (United States)

^b Gauthier Simulation Inc   (United States)

Author keywords

Children's uncertainty factor; Intraspecies uncertainty factor; Probabilistic risk assessment

Indexed keywords

HEALTH RISKS; PHYSIOLOGY; PROBABILITY; TOXIC MATERIALS; TUMORS;

TOXICOKINETICS;

RISK ASSESSMENT;

HEALTH RISK;

ADOLESCENT; ADULT; AGED; BODY WEIGHT; CANCER RISK; CHILD; CONFERENCE PAPER; FEMALE; HEART OUTPUT; HUMAN; INFANT; MALE; METHODOLOGY; MODEL; MONTE CARLO METHOD; ORGAN WEIGHT; PHARMACODYNAMICS; POPULATION RISK; PROBABILITY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SPECIES DIFFERENCE; TISSUE LEVEL; TOXICOKINETICS; TOXICOLOGICAL PARAMETERS;

ADOLESCENT; ADULT; AGED; BODY WEIGHT; CARDIAC OUTPUT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MONTE CARLO METHOD; MOTOR ACTIVITY; ORGAN SIZE; PHARMACOKINETICS; RESPIRATION; RISK ASSESSMENT; TOXICOLOGY;

EID: 0347052822     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0272-4332.2003.00398.x     Document Type: Conference Paper

References (25)

1. Pelekis, M., Gephart, L. A., & Lerman, S. E. (2001). Physiological model-based derivation of the adult and child pharmacokinetic intraspecies uncertainty factors for volatile organic compounds. Regulatory Toxicology and Pharmacology, 33, 12-20.
2. Andersen, M. E., Clewell, H. J., Gargas, M. L., MacNaughton, M. G., Reitz, R. H., Nolan, R. J., & McKenna, M. J. (1991). Physiologically based toxicokinetic modeling with dichloromethane, its metabolite carbon monoxide, and blood carboxyhemoglobin in rats and humans. Toxicology and Applied Pharmacology, 108, 14-27.
3. Simon, T. W. (1997). Combining physiologically based pharmacokinetic modeling with Monte Carlo simulation to derive an acute inhalation guidance value for trichloroethylene. Regulatory Toxicology and Pharmacology, 26, 257-270.
4. WHO. (2000). Air Quality Guidelines, Chapter 5.7. Dichloromethane. Copenhagen: Denmark.
5. USEPA. (1990). Exposure Factors Handbook. EPA-600/889/043. Washington, DC.
6. Health Canada. (1994). Human Health Risk Assessment for Priority Substances. Canadian Environmental Protection Act Report, Supply and Services Canada. Ottawa, Ontario.
7. Allan, M., & Richardson, G. M. (1998). Probability density functions describing 24-hr inhalation rates for use in human health risk assessments. Risk Analysis, 4, 379-408.
8. Pelekis, M. (In preparation). Development of probability density functions for probabilistic physiological models.
9. Malina, R. M. (1969). Quantification of fat, muscle and bone in man. Clinical Orthopedics and Related Research, 65, 9-38.
10. Thomas, R. S., Lytle, W. E., Keefe, T. J., Constan, A. A., & Yang, R. S. H. (1996). Incorporating Monte Carlo simulation into physiologically based pharmacokinetic models using advanced continuous simulation language (ACSL): A computational method. Fundamental and Applied Toxicology, 31, 19-28.
11. Nielsen, S. L. & Larsen, O. A. (1973). Relationship of subcutaneous adipose tissue blood flow to total body fat mass. 7th European Conf. Microcirculation, Aberdeen 1972, Part I, Bibl. Anat., No. 11, pp. 411-416 (Karger, Basel 1973).
12. El-Masri, H. A., Bell, D. A., & Portier, C. J. (1999). Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans. Toxicology and Applied Pharmacology, 158, 221-230.
13. Pelekis, M., Poulin, P., & Krishnan, K. (1995). An approach for incorporating tissue composition data into physiologically based pharmacokinetic models. Toxicology and Industrial Health, 11, 511-522.
14. Clewell, J. H. III. (2001). Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences of Tissue Dosimetry. Report submitted to American Chemistry Council, ICF Consulting.
15. Smith, A. E., Evans, M., & Davidian, M. (1998). Statistical properties of fitted estimates of apparent in vivo metabolic constants obtained from gas uptake data, I. Lipophilic and slowly metabolized VOCs. Inhalation Toxicology, 10, 383-409.
16. USEPA (United States Environmental Protection Agency). (1989). Interim Methods for Development of Inhalation Doses. EPA/600/888/066F.
17. NRC (National Research Council). (1980). Problems in risk estimation. In In Drinking Water and Health, Vol. 3. Washington, DC: National Academy Press.
18. USEPA (United States Environmental Protection Agency). (1985). Principles of Risk Assessment: A Nontechnical Review. Environ Corporation.
19. National Research Council. (1994). Science and Judgement. Washington, DC: National Academy Press.
20. Barton, H. A., Andersen, M. E., & Clewell, H. J. III. (1998). Harmonization: Developing consistent guidelines for applying mode of action and dosimetry information to cancer and noncancer risk assessment. Human and Ecological Risk Assessment, 4, 75-115.
21. Baird, S. J. S., Cohen, J. T., Graham, J. D., Shlyakhter, A. I., & Evans, J. S. (1996). Noncancer risk assessment: A probabilistic alternative to current practice. Human and Ecological Risk Assessment, 2(1), 79-102.
22. Gaylor, D. W., Kodell, R. L., Chen, J. J., & Krewski, D. (1999). A unified approach to risk assessment for cancer and noncancer endpoints based on benchmark doses and uncertainty/safety factors. Regulatory Pharmacology and Toxicology, 29, 151-157.
23. Swartout, J. C., Price, P. S., Dourson, M. L., Carlson-Lynch, H. L., &, Keenan, R. E. (1998). A probabilistic framework for the reference dose (probabilistic RfD). Risk Analysis, 18(3), 271-282.
24. Pelekis, M. (1998). Physiological model based determination of the interspecies toxicokinetic uncertainty factors for organic chemicals. Ph.D. thesis, Université de Montreal.
25. Pelekis, M., Nicolich, M. J., & Gauthier, J. S. (2002). Probabilistic framework for non-cancer risk assessments. Toxicologist, 66(1), Abstract No. 1655.